Evaluation of a Mobile Therapy for Elevated Depressive Symptoms

NACompletedINTERVENTIONAL
Enrollment

649

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

January 4, 2024

Study Completion Date

March 29, 2024

Conditions
Depressive SymptomsDepression
Interventions
BEHAVIORAL

Behavioral Activation Therapy app

Moodivate focuses on tracking daily activities, recording daily mood, and identifying new activities to complete that may help improve mood. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.

BEHAVIORAL

Behavioral Activation Therapy app + EHR

Moodivate focuses on tracking daily activities, recording daily mood, and identifying new activities to complete that may help improve mood. The participant's primary care provider at MUSC will be provided access to a Moodivate provider portal that was developed by study team. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.

BEHAVIORAL

Treatment as Usual

Participants will be provided educational material about mood management available via the EHR with the suggestion to discuss questions with their PCP. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Medical University of South Carolina

OTHER

NCT04463914 - Evaluation of a Mobile Therapy for Elevated Depressive Symptoms | Biotech Hunter | Biotech Hunter